Everest Pharmaceuticals – Quality Medicines from Bangladesh
Everest
Everest Pharmaceuticals Ltd. is a Bangladeshi pharmaceutical company founded by a group of pharmacists and managers with experience at local and multinational companies. Its head office is in the Tejgaon area of Dhaka.
Alongside general medicines, the company specialises in oncology, nephrology, haematology, virology and hepatology. Its portfolio includes generics of modern targeted cancer drugs, among them kinase inhibitors and anti-androgens, as well as treatments for liver and biliary diseases.
Everest's strategy builds on the TRIPS exemption for least developed countries, which include Bangladesh: while it keeps that status, a WTO decision allows it not to enforce pharmaceutical patents. This allows the company to make versions of new medicines that are still under patent elsewhere.
Its main plant is in the BSCIC industrial estate at Kanchpur (Sonargaon, Narayanganj district) and produces tablets, capsules, creams and ointments, liquids and prefilled syringes. A second plant, dedicated to active pharmaceutical ingredients, is under construction at Keraniganj near Dhaka.
Unifarm carries Everest medicines: Abemaxen (abemaciclib), Enzamide (enzalutamide), Renaxen (axitinib), Encoraf (encorafenib), Binixen (binimetinib), Lazerib (lazertinib), Adakras (adagrasib), Obeliva (obeticholic acid), Udiliva (ursodeoxycholic acid) and more — see the full list below.